Stanford's AI digital twin predicts aspirin plus lansoprazole could delay labor about 15 times longer than aspirin alone.
Roivant and Priovant report brepocitinib met the primary endpoint in Phase III uveitis trials. Read the latest results and ...
Olorofim meets its non-inferiority goal against AmBisome in the Phase III OASIS trial for invasive aspergillosis. Read full ...
Kyverna reports one-year Phase II data for miv-cel in stiff person syndrome and plans a rolling BLA filing. Read the full ...
Muna Therapeutics' oral TREM2 modulator MNA-001 showed no serious adverse events in Phase I. Read how the Phase II ...
Curis prices an $8.5M private placement at $0.51 per share to fund emavusertib CLL data in December 2026. Read the full story on the offering and runway.
Pennsylvania court awards Inovio $80.4M in breach-of-contract case over DNA plasmid supply deal with VGXI and GeneOne. Read the full ruling details now.
Novartis's Cosentyx is now approved in Europe for polymyalgia rheumatica, the first IL-17A inhibitor for this use. Read the full story to learn more today.
Alcon acquires Neurotech for USD 550m, gaining ENCELTO, the only FDA-approved MacTel type 2 cell therapy. Read how it expands Alcon's retina portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results